Banco Santander Central Hispano Aktie [WKN: 873816 / ISIN: US05964H1059]

Kurse + Charts + Realtime		News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (groß)	News + Adhoc	Bilanz/GuV	Termine	Zertifikate	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil	Optionsscheine	Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV	Knock-Outs
Historisch	Analysen

Kurse + Charts + Realtime
Kurs + Chart
Times + Sales
Börsenplätze
Historisch

News + Analysen
News + Adhoc
Analysen
Kursziele

Fundamental
Bilanz/GuV
Schätzungen
Dividende/GV
Analysen

Unternehmen
Termine
Profil

zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs

Nachrichten zu Banco Santander Central Hispano, SAShs Sponsored American Deposit.Receipt Repr.1 Sh

11.09.17		Regeneron and Sanofi Announce Positive Dupilumab Topline Results from Phase 3 Trial in Uncontrolled Persistent Asthma (PR Newswire)
05.09.17		Santander US Provides Update On Hurricane Harvey Relief Efforts (PR Newswire)
01.09.17		Sanofi Receives Tentative FDA Approval of Admelog® (insulin lispro injection) 100 Units/mL (PR Newswire)
01.09.17		Breakfast Technical Briefing on Banking Stocks -- Banco Santander, UBS Group, Lloyds Banking, and Royal Bank of Scotland (PR Newswire)
25.08.17		Regeneron and Sanofi to Present New Analyses from Praluent® (alirocumab) Injection Trials at the ESC Congress 2017 (PR Newswire)
23.08.17		ALM Intelligence Names KPMG a Global 'Leader' in Employee Experience Consulting (PR Newswire)
31.07.17		Sanofi Raises FY 2017 Business EPS Guidance to Broadly Stable at CER (PR Newswire)
28.07.17		GRUPO SANTANDER Q2 Attributable Profit Rises YoY - Quick Facts (RTTNews)
26.07.17		Stocks Under Scanner in the Banking Space -- Lloyds Banking, Banco Santander, UBS Group, and Royal Bank of Scotland (PR Newswire)
21.07.17		Sanofi Receives CHMP Positive Opinion for Dupixent® (dupilumab) to Treat Adult Patients with Moderate-to-Severe Atopic Dermatitis (PR Newswire)
21.07.17		Regeneron and Sanofi Receive Positive CHMP Opinion for Dupixent® (dupilumab) to Treat Adult Patients with Moderate-to-Severe Atopic Dermatitis (PR Newswire)
19.07.17		FORMULATRIX® Announces Unveiling of High-throughput Digital PCR System (PR Newswire)
18.07.17		Santander Bank Contributes Nearly $2.9 Million To 109 Non-Profit Organizations (PR Newswire)
17.07.17		Sanofi Pasteur Ships First of its U.S. Influenza Vaccine Doses for 2017-2018 Season (PR Newswire)
17.07.17		Santander Holdings USA, Inc. Announces The Completion And Final Results Of Its Tender Offer For Any And All Of Its 3.450% Senior Notes Due 2018 (PR Newswire)
17.07.17		Samuel Adams Launches Brewing the American Dream Collaboration Pack - In Stores This July (PR Newswire)
14.07.17		Santander Holdings USA, Inc. Announces Pricing Of Tender Offer For Any And All Of Its 3.450% Senior Notes Due 2018 (PR Newswire)
11.07.17		Santander And New England Revolution Announce 2017 Santander Soccer Scholars(SM) Program (PR Newswire)
10.07.17		Santander Holdings USA, Inc. Announces Pricing Of Private Offering Of Senior Notes (PR Newswire)
10.07.17		Santander Reportedly Plans To Increase Stake In U.S. Consumer Unit (RTTNews)
10.07.17		Santander Launches Ultimate Cash Back(SM) Credit Card: First Consumer Card To Offer Unlimited 1.5% Cash Back Rewards On All Purchases With No Annual Or Transaction Fees (PR Newswire)
10.07.17		Santander Holdings USA, Inc. Announces Proposed Private Offering Of Senior Notes (PR Newswire)
10.07.17		Santander Holdings USA, Inc. Announces Cash Tender Offer For Any And All Of Its 3.450% Senior Notes Due 2018 (PR Newswire)
04.07.17		Banco Santander Sees Nearly 24% Increase In H1 Profit - Quick Facts (RTTNews)
28.06.17		Santander Holdings USA Announces Capital Distributions and Maintains Capital Strength in Severe Economic Stress Scenario (PR Newswire)
27.06.17		Santander Names Bank Co-Presidents And Appoints Robert Rubino Head Of Corporate And Commercial Banking (PR Newswire)
27.06.17		Sanofi Announces Approval of Kevzara® (sarilumab) to Treat Adult Patients with Moderately to Severely Active Rheumatoid Arthritis (RA) in the European Union (PR Newswire)
27.06.17		Sanofi Announces Licensing of Kevzara® (sarilumab) to Treat Adult Patients with Moderately to Severely Active Rheumatoid Arthritis (RA) in the European Union (PR Newswire)
27.06.17		Regeneron and Sanofi Announce Approval of Kevzara® (sarilumab) to Treat Adult Patients with Moderately to Severely Active Rheumatoid Arthritis in the European Union (PR Newswire)
19.06.17		Pre-Market Technical Recap on Financial Stocks -- Lloyds Banking, Banco Santander, UBS Group, and Popular (PR Newswire)
15.06.17		Santander Bank Raises Its Prime Rate To 4.25% (PR Newswire)
15.06.17		Start Your Morning With a Cup of Coffee and an Ounce of Dengue Prevention (PR Newswire)
11.06.17		Sanofi and Regeneron Announce Positive Results from First Dedicated Studies Evaluating Praluent® (alirocumab) in Individuals with Diabetes and Hypercholesterolemia (PR Newswire)
11.06.17		Regeneron and Sanofi Announce Positive Results from First Dedicated Studies Evaluating Praluent® (alirocumab) in Individuals with Diabetes and Hypercholesterolemia (PR Newswire)
10.06.17		New Analysis Shows Sanofi's Soliqua® 100/33 Lowered HbA1c by More Than 2 Percent in Patients with Screening Levels Greater than 9 Percent (PR Newswire)
10.06.17		In Senior Adults Treated with Basal Insulin, Switching to Sanofi's Toujeo® Halved Hypoglycemia Risk (PR Newswire)
07.06.17		Banco Santander Acquires Banco Popular; Plans EUR 7 Bln Capital Increase (RTTNews)
04.06.17		Regeneron and Sanofi Present Positive Study Results for Investigational PD-1 Antibody REGN2810 at American Society of Clinical Oncology (ASCO) Annual Meeting (PR Newswire)
22.05.17		Sanofi and Regeneron Announce FDA Approval of Kevzara® (sarilumab) for the Treatment of Moderately to Severely Active Rheumatoid Arthritis in Adult Patients (PR Newswire)
22.05.17		Regeneron and Sanofi Announce FDA Approval of Kevzara® (sarilumab) for the Treatment of Moderately to Severely Active Rheumatoid Arthritis in Adult Patients (PR Newswire)
22.05.17		Diageo Brands Awarded Top Honors For Superior Quality At The 17th Annual San Francisco World Spirits Competition (PR Newswire)
17.05.17		Santander Bank Announces Initiative To Support Entrepreneurs In Greater Boston's Underserved Communities (PR Newswire)
08.05.17		Global Net Lease Announces Operating Results for First Quarter 2017 (PR Newswire)
03.05.17		NRCC Sisters in the Brotherhood to Hold 4th Annual Open House (PR Newswire)
02.05.17		Santander Bank Rallies Behind National Small Business Week With Events, Promotions and a $25,000 Donation to Leading Non-Profit 'Entrepreneurship for All' (PR Newswire)
02.05.17		Survey Results Show Eighty Percent of Rheumatoid Arthritis Patients Report Life-Altering Pain Daily or Multiple Times a Week, Despite Treatment (PR Newswire)
02.05.17		Survey Results Show Eighty Percent of Rheumatoid Arthritis Patients Report Life-Altering Pain Daily or Multiple Times a Week, Despite Treatment (PR Newswire)
28.04.17		Sanofi Delivers Robust Q1 2017 Financial Results (PR Newswire)
28.04.17		Regeneron and Sanofi Announce Kevzara® (sarilumab) Biologics License Application Resubmission Accepted for Review by U.S. FDA (PR Newswire)
26.04.17		Banco Santander Q1 Profit Climbs On Higher Net Interest Income - Quick Facts (RTTNews)

Zurück | 1 | 2 | 3 | 4 | Weiter

Newssuche

Meistgelesene Nachrichten

DeepSeek sorgt nur noch partiell für anhaltenden Schock: SoftBank-Aktien & Co. auf Talfahrt - NVIDIA nach Rekordverlust erholt

Negative Entwicklungen am Krypto-Markt: Wieso Bitcoin, Ethereum, Ripple & Co. nachgeben

Pierer Mobility-Aktie dreht ins Minus: KTM-Mutter Pierer Mobility-Aktionäre stimmen für Kapitalerhöhung

Broadcom, Infineon-Aktie, AMD & Co massiv leichter: DeepSeek wirbelt KI-Branche durcheinander - NVIDIA bricht ein

Baumann: AfD stimmt Unions-Gesetz zur 'Zustrombegrenzung' zu

STRABAG-Urteil - RBI: Aktienpaket könnte versteigert werden - Gewinnprognose angehoben - Aktien höher

finanzen.net Apps

ETF-Sparplan

Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.

JETZT MEHR ERFAHREN

Aktien ATX DAX EuroStoxx 50 Dow Jones NASDAQ 100 Nikkei 225 S&P 500

Kontakt - Impressum - Werbung

Sitemap - Datenschutz - Disclaimer - AGB - Privatsphäre-Einstellungen

Für die aufgeführten Inhalte kann keine Gewährleistung für die Vollständigkeit, Richtigkeit und Genauigkeit übernommen werden.
Kursinformationen von SIX Financial Information Deutschland GmbH. Verzögerung 15 Min. (Nasdaq, NYSE: 20 Min.).
© 1999-2025 finanzen.net GmbH

*Werbehinweise: Die Billigung des Basisprospekts durch die Bundesanstalt für Finanzdienstleistungsaufsicht ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.

⁵Hinweis zu Plus500: 82% der Kleinanlegerkonten verlieren Geld beim CFD-Handel mit diesem Anbieter. Sie sollten überlegen, ob Sie es sich leisten können, das hohe Risiko einzugehen, Ihr Geld zu verlieren. Plus500UK Ltd ist zugelassen und reguliert durch Financial Conduct Authority (FRN 509909). Plus500CY Ltd authorized & regulated by CySEC (#250/14).

Währungsrechner News Devisen Dollarkurs Aktienkurse Bitcoin Rohstoffe Fonds

Portfolioname: Watchlistname:
Portfolio:
Name:
Typ:
ISIN:
Börse:
Anzahl:
Aktueller Kurs:
Kurszeit:
Kaufpreis:
Kaufdatum:	30.01.2025 13:08
Kaufwert:	EUR
	Hinzufügen Speichern